news.cision.com

Evolution Gaming, leading provider of Live Casino solutions, has announced that it has signed a new agreement with existing client Unibet, this time for the US market.Unibet already works closely with Evolution in Europe, where it operates using Evolution’s generic Live Casino tables, a dedicated environment at Evolution’s Riga studios and a selection of native speaking tables at Evolution’s Malta studios. As part of its first foray into the US market, Unibet will use Evolution’s new US studio, which opened in Atlantic City in mid-August, to deliver Live Casino services to players in New

Changes in Volvo’s management

Roger Alm has been appointed as a new member of Volvo’s Group Executive Board and President Volvo Trucks. He will replace Claes Nilsson, who after a long and successful career will retire from his position from January 1, 2019. In parallel, Diana Niu has been appointed as a member of the Group Executive Board and Executive Vice President Group Human Resources for Volvo Group. Roger Alm, born in 1962, currently holds the position as President for the European Division at Volvo Trucks. His career at Volvo Trucks began in 1989 and he has held many senior positions at the company,

New CEO appointed for Intervacc – a innovative and expanding vaccine company

Intervacc, a Swedish innovative vaccine company listed on Nasdaq First North, has appointed Andreas Andersson as CEO. The Company thus gains a valuable addition to lead the expansion and strategic development on the growth journey for a new generation of animal health vaccines. This appointment follows on the clinical success of Intervacc’s lead vaccine project Strangvac®. This strengthening of Intervacc is part of Intervacc's development and commercialization of animal vaccine based on the company's vaccine platform. Intervacc’s current CEO and co-founder, Professor Flock, will continue to

Panion starts clinical study in dogs

Panion Animal Health AB develops a novel gene therapy treatment for dogs with epilepsy. The first clinical trial will be conducted at Long Island Veterinary Specialists, Ophthalmology, Surgery, Internal Medicine, Emergency, PLLC (“LIVS”) in New York, USA. It is a pilot study to evaluate the efficacy of the treatment in patient dogs with idiopathic epilepsy. It is the first time that the gene therapy treatment is made available for client-owned family dogs. The study activities will start immediately, and the first dog-patient is expected to be enrolled in Q1-19. Depending on the speed of

Brighter recruits Global Product Manager - Diabetes.

Brighter recruits Thor Sundsvik as Global Product Manager – Diabetes effective immediately. In this new role at Brighter, Thor will oversee and drive the commercialization of Brighter’s unique data-driven and mobile diabetes management solutions. Primarily Actiste ® Diabetes Management as a Service. Thor has extensive experience in sales and business development in the medtech and healthcare industry, particularly within digital solutions for treatment of chronic diseases in the home, and anesthesia. He has also been involved in the establishment of specialist

International manufacturing group SACMI signs agreement for global roll‑out of XMReality Remote Guidance

Linköping, Sweden ‑ XMReality AB (publ) (NASDAQ First North: XMR), an international leader in AR‑enabled knowledge sharing, announces that the international manufacturing group SACMI has signed an agreement for a global roll-out. SACMI will use the XMReality Remote guidance solution to enable a global roll-out of an enhanced service offering to its customers. Order value is approx. 0.4 MSEK annual recurring revenue.SACMI has decided to perform a global roll-out of XMReality Remote Guidance to its customers, thus strengthening its service offering and making it possible to generate new

Catella and Söderberg & Partners in strategic partnership

Catella Bank S.A., a subsidiary to Catella AB (publ), has entered an agreement to divest 51% of the Wealth Management operations in Sweden to Söderberg & Partners for approximately SEK 36 Million. Catella’s ownership in the joint venture structure is expected to generate positive cash flow which is an important part of the value of the transaction. The parties will also enter a strategic partnership. Catella will continue to develop alternative investment products to this client segment for the entire wealth advisory industry.As part of the strategic review of Catella’s Banking operation

NetEnt reorganizes to increase profitability and competitiveness

As previously communicated, NetEnt is taking action to optimize its operations. Now, the Company streamlines and restructures the organization, which leads to staff reductions in Stockholm. The reorganization is expected to result in non-recurring costs of approximately SEK 25 million, which will be booked in the fourth quarter of 2018.The restructuring of NetEnt affects 55 full-time positions, most of which are in Stockholm and within corporate support functions. The changes are taking place during December and will lead to a reallocation of resources to increased game production. The

Nepa has carried out a directed share issue of 714,835 shares, raising proceeds of SEK 39.3 million

THE INFORMATION IN THIS PRESS RELEASE MAY NOT BE ANNOUNCED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, OR IN ANY OTHER JURISDICTION WHERE THE RELEASE, PUBLICATION OR DISTRIBUTION OF THE INFORMATION WOULD NOT COMPLY WITH OR REQUIRE REGISTRATION UNDER APPLICABLE LAWS AND REGULATIONS.Press release Stockholm, 12 December 2018 Nepa has carried out a directed share issue of 714,835 shares, raising proceeds of SEK 39.3 million Nepa AB (publ) (“Nepa” or the “

Inhalation Sciences receives large order from leading company in the inhalation field

Inhalation Sciences (ISAB) has received an order for a PreciseInhale system, and DissolvIt, the system’s unique in vitro module for studying particle dissolution. The order is initially valued at approximately 2.0 MSEK.PreciseInhale and its range of controlled aerosol exposure modules comprise a total solution for companies carrying out pre-clinical inhalation and aerosol research. DissolvIt is an in vitro module developed to characterize the dissolution rate of particles, and how this affects how a drug is absorbed in the body. DissolvIt is a unique tool. It gives companies developing

Skanska sells retirement home in Växjö, Sweden, for about SEK 240 M to Nordiska Vårdhem AB

Skanska has sold a retirement home in Växjö, Sweden, for about SEK 240 M. Buyers are Nordiska Vårdhem AB (Northern Horizons Health Property Fund) and the tenant is Humana AB. The transaction will be booked in the Commercial Property Development stream in the fourth quarter of 2018. The retirement home is in operation since June 2017. It will be handed over on January 31, 2019.The project comprises a retirement home with about 70 apartments spread over four floors. On the roof there is a terrace and a small greenhouse for the residents. It is a traditional retirement home with a strong

Telia Company divests its interest in Kcell and dissolves Fintur partnership with Turkcell

Telia Company and Fintur Holdings B.V. (Fintur), jointly owned by Telia Company and Turkcell, have agreed to sell their 75 percent holding in the leading Kazakhi telecommunications operator Kcell JSC, to the telecom operator Kazakhtelecom JSC, a company controlled by the government of the Republic of Kazakhstan through the sovereign wealth fund Samruk-Kazyna. Telia Company has also signed an agreement to acquire Turkcell’s share in Fintur in a separate transaction to become the sole shareholder of the company, which enables Telia Company to repatriate cash from Fintur.“I’m glad to announce

FINANCIAL CALENDAR FOR TECHSTEP ASA

Wed, Dec 12, 2018 07:45 CET

FINANCIAL YEAR 2018 25.04.2019 – Annual General Meeting15.02.2019 – Quarterly Report – Q4 FINANCIAL YEAR 2019 21.08.2019 – Half-yearly Report19.03.2020 – Annual Report22.04.2020 – Annual General Meeting10.05.2019 – Quarterly Report – Q108.11.2019 – Quarterly Report – Q313.02.2020 – Quarterly Report – Q4 This information is published pursuant to the requirements set out in the Continuing obligations.

Change in ownership of Tornet Bostadsproduktion

Ownership of Tornet has changed since Folksam, Peab and Balder acquired Riksbyggen’s shares in the company. Peab and Balder already owned 31 percent each and Folksam owned 19 percent. The remaining shareholders have now acquired Riksbyggen’s 19 percent shareholding so that ownership is equally divided, giving each shareholder a third of the company.Ownership of Tornet has changed since Folksam, Peab and Balder acquired Riksbyggen’s shares in the company. Peab and Balder already owned 31 percent each and Folksam owned 19 percent. The remaining shareholders have now acquired Riksbyggen’s 19

Alfa Laval has signed an agreement to divest the major part of its “Greenhouse” activity, to the LU-VE Group

Wed, Dec 12, 2018 07:45 CET

Alfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – has signed an umbrella agreement with the LU-VE Group to sell parts of its air heat exchanger business, related to commercial/industrial air heat exchangers, currently placed in the Greenhouse division. The closing of the agreement is expected during first half of 2019.The product group commercial/industrial air heat exchangers represent the major part of today’s Greenhouse. It was moved there in 2016, along with a few other selected product groups, to give it the best possible conditions to improve

KfW Development Bank exercises options for GET FiT Zambia with Multiconsult

Reference is made to the stock market announcement on 7 May 2018 where Multiconsult announced a contract award with KfW Development Bank for GET FiT Zambia.KfW Development Bank has exercised options for the second phase of the contract. The options value is approximately NOK 22 million. Multiconsult is tasked with the implementation of the GET FiT hydropower procurement (100 MW), as well as follow-ups and supervision. The optional services are extending the project duration from originally three years to now approximately six years.The contract with KfW on the GET FiT Programme in Zambia

BerGenBio Presents Key Results from PhII Programme with Selective AXL Inhibitor Bemcentinib at DNB’s 9th Annual Nordic Healthcare Conference

· Bemcentinib proof of concept clinical data as monotherapy and in combination confirms focus on lung cancer & leukaemia · AXL biomarker correlation supports bemcentinib’s proposed MoA, potential for Companion Diagnostic · Significant milestones expected over next 12 monthsBergen, Norway, 12 Dec 2018 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company focused on developing a pipeline of first-in-class AXL kinase inhibitors to treat multiple cancer indications, announces that the Company will be presenting key results from its Phase II clinical programme with

RecRight Video Interviews Now Live on SAP® App Center

By integrating with SAP SuccessFactors Recruiting, RecRight Video Interviews helps companies find top talent with ease and cost-effectiveness.Helsinki — 12.12.2018 — RecRight today announced that its Video Interviews tool is now available on the SAP® App Center , the digital marketplace for SAP partner offerings. RecRight Video Interviews integrates with the SAP® SuccessFactors® Recruiting solution and delivers efficiency throughout the entire recruitment process as well as a smooth

Ericsson releases its 10 hot consumer trends for 2019